113 related articles for article (PubMed ID: 15542712)
1. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications.
Hanson GR; Sandoval V; Riddle E; Fleckenstein AE
Ann N Y Acad Sci; 2004 Oct; 1025():146-50. PubMed ID: 15542712
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.
Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2003 Mar; 304(3):1181-7. PubMed ID: 12604695
[TBL] [Abstract][Full Text] [Related]
3. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
Volz TJ; Farnsworth SJ; King JL; Riddle EL; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2007 Nov; 323(2):738-45. PubMed ID: 17693585
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.
Truong JG; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2004 May; 492(2-3):143-7. PubMed ID: 15178358
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
[TBL] [Abstract][Full Text] [Related]
7. Bupropion increases striatal vesicular monoamine transport.
Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent effects of methamphetamine on VMAT-2.
Rau KS; Truong JG; Wilkins DG; Fleckenstein AE; Hanson GR
Ann N Y Acad Sci; 2006 Aug; 1074():154-9. PubMed ID: 17105913
[TBL] [Abstract][Full Text] [Related]
10. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
[TBL] [Abstract][Full Text] [Related]
11. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.
Riddle EL; Topham MK; Haycock JW; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2002 Aug; 449(1-2):71-4. PubMed ID: 12163108
[TBL] [Abstract][Full Text] [Related]
12. The methamphetamine experience: a NIDA partnership.
Hanson GR; Rau KS; Fleckenstein AE
Neuropharmacology; 2004; 47 Suppl 1():92-100. PubMed ID: 15464128
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.
Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
J Neurosci; 2002 Oct; 22(19):8705-10. PubMed ID: 12351745
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
Truong JG; Newman AH; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2004 Nov; 504(1-2):27-32. PubMed ID: 15507217
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced spectrin proteolysis in the rat striatum.
Staszewski RD; Yamamoto BK
J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
[TBL] [Abstract][Full Text] [Related]
16. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.
Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE
Ann N Y Acad Sci; 2008 Oct; 1139():285-90. PubMed ID: 18991873
[TBL] [Abstract][Full Text] [Related]
18. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
Volz TJ; Hanson GR; Fleckenstein AE
J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum.
Volz TJ; Bjorklund NL; Schenk JO
Synapse; 2005 Sep; 57(3):175-8. PubMed ID: 15945061
[TBL] [Abstract][Full Text] [Related]
20. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.
Hogan KA; Staal RG; Sonsalla PK
J Neurochem; 2000 May; 74(5):2217-20. PubMed ID: 10800969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
